-
Signature
-
Danielle White, Attorney-in-Fact for John M. Miller
-
Issuer symbol
-
ROK
-
Transactions as of
-
18 Nov 2024
-
Net transactions value
-
-$83,803
-
Form type
-
4
-
Filing time
-
20 Nov 2024, 17:37:15 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ROK |
Common Stock |
Options Exercise |
$48,605 |
+467 |
+9.7% |
$104.08 |
5,267 |
18 Nov 2024 |
Direct |
F1 |
| transaction |
ROK |
Common Stock |
Sale |
$132,660 |
-467 |
-8.9% |
$284.07 |
4,800 |
18 Nov 2024 |
Direct |
F1, F2 |
| transaction |
ROK |
Common Stock |
Options Exercise |
$92,552 |
+800 |
+17% |
$115.69 |
5,600 |
18 Nov 2024 |
Direct |
|
| transaction |
ROK |
Common Stock |
Tax liability |
$92,300 |
-326 |
-5.8% |
$283.13 |
5,274 |
18 Nov 2024 |
Direct |
|
| holding |
ROK |
Common Stock |
|
|
|
|
|
469 |
18 Nov 2024 |
By Savings Plan |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ROK |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-467 |
-34% |
$0.000000 |
900 |
18 Nov 2024 |
Common Stock |
467 |
$104.08 |
Direct |
F4 |
| transaction |
ROK |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-800 |
-100% |
$0.000000 |
0 |
18 Nov 2024 |
Common Stock |
800 |
$115.69 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: